Status:

COMPLETED

The Effect of Losartan on Emotional Processing in Healthy Volunteers

Lead Sponsor:

University of Oxford

Conditions:

Healthy Volunteers

Eligibility:

All Genders

18-50 years

Phase:

NA

Brief Summary

This experimental medicine study explores whether a single dose of losartan (50mg) versus placebo affects the processing of positive and negative stimuli, using fMRI.

Detailed Description

Losartan has been shown to accelerate fear extinction in animals and to prevent the development of anxiety disorders in humans, emphasising its potential to possibly enhance exposure therapy in humans...

Eligibility Criteria

Inclusion

  • willing and able to provide informed consent
  • male or Female, aged 18-50
  • body mass index (BMI) of 18-30 kg/m2
  • fluent English skills
  • non- or light-smoker (\< 5 cigarettes a day)

Exclusion

  • Female participant who is pregnant or breast-feeding
  • central nervous system (CNS) active medication during the last 6 weeks
  • Current blood pressure/other heart medication (esp. aliskiren or beta blockers)
  • Intravascular fluid depletion
  • Past or present DSM-IV (Diagnostic and Statistical Manual of Mental Disorders) axis-I diagnosis
  • Alcohol or substance abuse
  • First-degree family member with a history of a severe psychiatric disease
  • Impaired liver or kidney function
  • Lifetime history of epilepsy or other neurological disease, systemic infection, or clinically significant hepatic, cardiac, obstructive respiratory, renal, cerebrovascular, metabolic, endocrine or pulmonary disease or disorder which, in the opinion of the investigator, may either put the participants at risk because of participation in the study, or may influence the result of the study, or the participant's ability to participate in the study.
  • Insufficient English skills
  • participated in another study involving certain medication during last 6 weeks
  • Contraindication to magnet resonance imaging (MRI) scanning (e.g. pacemaker)

Key Trial Info

Start Date :

June 1 2016

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 30 2017

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT03434054

Start Date

June 1 2016

End Date

June 30 2017

Last Update

February 19 2018

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.